Who invested in Rapafusyn Pharmaceuticals?
Rapafusyn Pharmaceuticals's investors include 3E Bioventures.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2025, from 1 source
From Rapafusyn Pharmaceuticals's own website: 2 on the team.
Rapafusyn Pharmaceuticals's investors include 3E Bioventures.
Rapafusyn Pharmaceuticals has raised $16M across 1 round since 2025.
Rapafusyn Pharmaceuticals's most recent round was a Series A of $16M in Sept 2025.
Its most recent round, $16M in Sept 2025, is also its largest on record.
Rapafusyn Pharmaceuticals's first round on record, in Sept 2025, was backed by 3E Bioventures.
Rapafusyn Pharmaceuticals's latest named round is a Series A, in Sept 2025.
Rapafusyn Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.